Status:
COMPLETED
Efficacy of High-oleic Canola and Flaxseed Oils for Hypercholesterolemia and Cardiovascular Disease Risk Factors
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
Canola Council of Canada
Flax Canada 2015 Inc.
Conditions:
Cardiovascular Disease
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the efficacy of high-oleic canola oil and a high-oleic canola/flaxseed oil blend as compared to a typical Western diet on plasma lipids, fatty acid profiles, and...
Eligibility Criteria
Inclusion
- Fasting serum LDL-Cholesterol \>3.0 mmol/L
- Body mass index (BMI) between 22-36 kg/m2
Exclusion
- smoking
- use of lipid lowering therapy
- documented cardiovascular/atherosclerotic disease
- inflammatory disease
- diabetes
- uncontrolled hypertension
- kidney disease
- other systemic diseases
- cancer
- chronic alcohol consumption (\> 2 servings/day)
- excessive exercise expenditure (\> 4000 kcal/week)
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00927199
Start Date
September 1 2007
End Date
June 1 2008
Last Update
February 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba
Winnipeg, Manitoba, Canada, R3T 6C5